secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2022-05-24T23:59:59+00:00
Accession:  0001682852-22-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna CEO Bancel amends 10b5-1 plan to exercise 4.6M options; expects to donate $355M proceeds
--------------------------------------------------------------------------------

- CEO Bancel amended 10b5-1 plan to exercise 4,587,155 shares at $0.99/share (option from 2013, expiring Aug 2023).
- Exercise schedule: 40,000 shares each Wednesday and Thursday starting May 25, 2022, until fully exercised.
- After-tax proceeds (~$355M at ~$140/sh) to be donated to charity; ~$280M in taxes paid.
- Bancel's family entity OCHA LLC continues selling 10,000 shares each Thursday under separate 10b5-1 plan through end of 2022.
- Bancel terminated prior 10b5-1 plans for gifts/sales in March 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285222000033/0001682852-22-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285222000033/mrna-20220524.htm
  HTML page:      https://secwatch.observer/filing/0001682852-22-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer